Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rienk Offringa

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Cancer Research|February 5, 2008
Self-tolerance does not restrict the CD4+ T-helper response against the p53 tumor antigenMarjolein M Lauwen, Sander Zwaveling, Linda de Quartel, et al.
Cancer Research|October 17, 2008
Balancing between antitumor efficacy and autoimmune pathology in T-cell-mediated targeting of carcinoembryonic antigenRinke Bos, Suzanne van Duikeren, Hans Morreau, et al.
Plos One|March 23, 2011
Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genesRezaul Karim, Craig Meyers, Claude Backendorf, et al.
The Journal of Experimental Medicine|December 30, 2009
The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defectsCláudia C Oliveira, Peter A van Veelen, Bianca Querido, et al.
Vaccine|November 25, 2006
Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonistsMarij J P Welters, Martijn S Bijker, Susan J F van den Eeden, et al.
Experimental Hematology & Oncology|March 11, 2023
Secretogranin II influences the assembly and function of MHC class I in melanomaTamara Steinfass, Juliane Poelchen, Qian Sun, et al.
Frontiers in Immunology|September 27, 2019
Sensitization of Tumors for Attack by Virus-Specific CD8+ T-Cells Through Antibody-Mediated Delivery of Immunogenic T-Cell EpitopesJulian P Sefrin, Lars Hillringhaus, Olaf Mundigl, et al.
Cancer Research|September 19, 2007
Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccinationBenedict Chambers, Per Grufman, Vanoohi Fredriksson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2002
CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunityGeertje J D van Mierlo, Annemieke Th den Boer, Jan Paul Medema, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
Intraocular tumor antigen drains specifically to submandibular lymph nodes, resulting in an abortive cytotoxic T cell reactionZita F H M Boonman, Geertje J D van Mierlo, Marieke F Fransen, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Cancer Research|February 5, 2008
Self-tolerance does not restrict the CD4+ T-helper response against the p53 tumor antigenMarjolein M Lauwen, Sander Zwaveling, Linda de Quartel, et al.
Cancer Research|October 17, 2008
Balancing between antitumor efficacy and autoimmune pathology in T-cell-mediated targeting of carcinoembryonic antigenRinke Bos, Suzanne van Duikeren, Hans Morreau, et al.
Plos One|March 23, 2011
Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genesRezaul Karim, Craig Meyers, Claude Backendorf, et al.
The Journal of Experimental Medicine|December 30, 2009
The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defectsCláudia C Oliveira, Peter A van Veelen, Bianca Querido, et al.
Vaccine|November 25, 2006
Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonistsMarij J P Welters, Martijn S Bijker, Susan J F van den Eeden, et al.
Experimental Hematology & Oncology|March 11, 2023
Secretogranin II influences the assembly and function of MHC class I in melanomaTamara Steinfass, Juliane Poelchen, Qian Sun, et al.
Frontiers in Immunology|September 27, 2019
Sensitization of Tumors for Attack by Virus-Specific CD8+ T-Cells Through Antibody-Mediated Delivery of Immunogenic T-Cell EpitopesJulian P Sefrin, Lars Hillringhaus, Olaf Mundigl, et al.
Cancer Research|September 19, 2007
Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccinationBenedict Chambers, Per Grufman, Vanoohi Fredriksson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2002
CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunityGeertje J D van Mierlo, Annemieke Th den Boer, Jan Paul Medema, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
Intraocular tumor antigen drains specifically to submandibular lymph nodes, resulting in an abortive cytotoxic T cell reactionZita F H M Boonman, Geertje J D van Mierlo, Marieke F Fransen, et al.
Pageof 12